- Home
- PIII vs RDI Comparison
PIII vs RDI Comparison
Compare PIII & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- RDI
- Stock Information
- Founded
- PIII 2015
- RDI 1937
- Country
- PIII United States
- RDI United States
- Employees
- PIII N/A
- RDI N/A
- Industry
- PIII Medical/Nursing Services
- RDI Movies/Entertainment
- Sector
- PIII Health Care
- RDI Consumer Discretionary
- Exchange
- PIII Nasdaq
- RDI Nasdaq
- Market Cap
- PIII 30.8M
- RDI 30.1M
- IPO Year
- PIII N/A
- RDI N/A
- Fundamental
- Price
- PIII $8.18
- RDI $1.37
- Analyst Decision
- PIII Buy
- RDI Hold
- Analyst Count
- PIII 2
- RDI 1
- Target Price
- PIII $16.25
- RDI $2.40
- AVG Volume (30 Days)
- PIII 11.0K
- RDI 33.3K
- Earning Date
- PIII 05-15-2025
- RDI 05-23-2025
- Dividend Yield
- PIII N/A
- RDI N/A
- EPS Growth
- PIII N/A
- RDI N/A
- EPS
- PIII N/A
- RDI N/A
- Revenue
- PIII $1,500,455,000.00
- RDI $210,527,000.00
- Revenue This Year
- PIII N/A
- RDI $9.74
- Revenue Next Year
- PIII $6.41
- RDI $6.39
- P/E Ratio
- PIII N/A
- RDI N/A
- Revenue Growth
- PIII 18.48
- RDI N/A
- 52 Week Low
- PIII $7.00
- RDI $1.17
- 52 Week High
- PIII $39.50
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- PIII 40.82
- RDI 55.03
- Support Level
- PIII $8.17
- RDI $1.34
- Resistance Level
- PIII $8.71
- RDI $1.30
- Average True Range (ATR)
- PIII 0.48
- RDI 0.07
- MACD
- PIII -0.07
- RDI 0.01
- Stochastic Oscillator
- PIII 11.85
- RDI 60.87
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.